|
KDM1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.66350000002846E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.456100E-03 |
| Normal-vs-Stage2 |
2.653900E-02 |
| Normal-vs-Stage3 |
5.459500E-02 |
| Normal-vs-Stage4 |
9.947800E-02 |
| Stage1-vs-Stage2 |
4.747400E-01 |
| Stage1-vs-Stage3 |
9.966800E-01 |
| Stage1-vs-Stage4 |
7.174200E-01 |
| Stage2-vs-Stage3 |
5.008400E-01 |
| Stage2-vs-Stage4 |
3.538600E-01 |
| Stage3-vs-Stage4 |
8.204400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.8026999999996E-06 |
| Normal-vs-AfricanAmerican |
8.539500E-03 |
| Normal-vs-Asian |
6.962600E-01 |
| Caucasian-vs-AfricanAmerican |
3.238200E-01 |
| Caucasian-vs-Asian |
5.114600E-01 |
| AfricanAmerican-vs-Asian |
6.083400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13949999999796E-05 |
| Normal-vs-Female |
2.614900E-04 |
| Male-vs-Female |
2.204000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.499040E-01 |
| Normal-vs-Extreme_Weight |
8.123800E-02 |
| Normal-vs-Obese |
2.801000E-04 |
| Normal-vs-Extreme_Obese |
2.701400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.606800E-01 |
| Normal_Weight-vs-Obese |
1.302040E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.987600E-01 |
| Extreme_Weight-vs-Obese |
1.676110E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.112800E-01 |
| Obese-vs-Extreme_Obese |
6.209800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.598300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.5022299999945E-05 |
| Normal-vs-Age(61-80Yrs) |
5.179400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.153600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.126600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.174600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.429200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.031400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.790600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.793000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.60140000049891E-07 |
| Normal-VS-Type2 PRCC |
8.285000E-03 |
| Normal-VS-KIRP CIMP |
3.557000E-01 |
| Normal-VS-Unclassified PRCC |
1.470310E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.396800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.975800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.107400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.548200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.589000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.960200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.619200E-01 |
| Normal-vs-N1 |
2.111600E-02 |
| Normal-vs-N2 |
7.278800E-01 |
| N0-vs-N1 |
7.989900E-02 |
| N0-vs-N2 |
6.190000E-01 |
| N1-vs-N2 |
2.699200E-01 |
|
|
